Antimicrobial Resistance of Bacteria in Biofilms | CMAC

Antimicrobial Resistance of Bacteria in Biofilms

Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(1):51-58

​ Chebotar I.V., Mayanskiy A.N., Konchakova E.D., Lazareva A.V., Chistyakova V.P.
bacterial biofilms antimicrobial resistance extracellular matrix
Section
Antimicrobial Resistance
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(1):51-58

Abstract

Different mechanisms of antimicrobial resistance development in biofilm bacteria are reviewed in the article. Practical approaches to the susceptibility testing of bacteria in biofilms are analyzed.

  • 1. Бехало В.А., Бондаренко В.М., Сысолятина Е.В., Нагурская Е.В. Иммунобиологические особенности бактериальных клеток медицинских биоплёнок. Журн Микробол 2010; 4:97-105.
  • 2. Costerton J. W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-22.
  • 3. Peeters E., Nelis H. J., Coenye T. Evaluation of the efficacy of disinfection procedures against Burkholderia cenocepacia biofilms. J Hosp Infect 2008; 70:361-8.
  • 4. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167-93.
  • 5. Qu Y., Daley A.J, Istivan T.S, Garland S.M, Deighton M.A. Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation. Ann Clin Microbiol Antimicrob 2010; 27:9-16.
  • 6. Weigel L.M., Donlan R.M., Shin D.H., et al. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother 2007; 51:231-8.
  • 7. Маянский А.Н., Чеботарь И.В. Стафилококковые биоплёнки: структура, регуляция, отторжение. Журн микробиол 2011, 1: 101-8.
  • 8. Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. Смоленск: НИИАХ СГМА, 2002. – 586 с.
  • 9. Yu J., Wu J., Francis K.P., Purchio T.F., Kadurugamuwa J.L. Monitoring in vivo fitness of rifampicinresistant Staphylococcus aureus mutants in a mouse biofilm infection model. J Antimicrob Chemother 2005; 55:528-34.
  • 10. Hibma A.M, Jassim S.A, Griffiths M.W. In vivo bioluminescence to detect the attachment of L-forms of Listeria monocytogenes to food and clinical contact surfaces. Int J Food Microbiol 1996; 33:157-67.
  • 11. Ciofu O. Pseudomonas aeruginosa chromosomal betalactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. APMIS Suppl 2003; 116:41-7.
  • 12. Mandsberg L.F, Ciofu O., Kirkby N., Christiansen L.E, Poulsen H.E., Høiby N. Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. Antimicrob Agents Chemother 2009; 53:2483-91.
  • 13. Pagel M., SimonetV., Li J., Lallemand M., Lauman B., Delcou A.H. Phenotypic characterization of pore mutants of the Vibrio cholerae рorin OmpU. J Bacteriol 2007; 189:8593-600.
  • 14. Льюис К. Персистирующие клетки и загадка выживания биоплёнок. Биохимия 2005, 70(2):327-36.
  • 15. Плакунов В.К., Стрелкова Е.А., Журина М.В. Персистенция и адаптивный мутагенез в биоплёнках. Микробиол 2010; 79(4):447-58.
  • 16. Lewis K. Persister cells. Annu Rev Microbiol 2010; 64:357-72.
  • 17. Гостев В.В., Сидоренко С.В. Бактериальные биоплёнки и инфекции. Журн инфектол 2010; 2(3):4-15.
  • 18. Lewis K. Pathogen resistance as the origin of kin altruism. J Theor Biol 1998; 193:359-63.
  • 19. Романова Ю.М., Гинцбург А.Л. Бактериальная биоплёнка как естественная форма существования бактерий в окружающей среде и организме хозяина. Журн Микробиол 2011; 3: 99-109.
  • 20. Dunne W.M. Jr. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev 2002; 15:155-66.
  • 21. Suci P.A., Mittelman M.W., Yu F.P., Geesey G.G. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 1994; 38:2125-33.
  • 22. Amorena B., Gracia E., Monzon M., et al. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 1999; 44:43-55.
  • 23. Sadovskaya I., Vinogradov E., Li J., Hachani A., Kowalska K., Filloux A. High-level antibiotic resistance in Pseudomonas aeruginosa biofilm: the ndvB gene is involved in the production of highly glycerol-phosphorylated β-(1→3)-glucans, which bind aminoglycosides. Glycobiology 2010; 20:895-904.
  • 24. Farber B. F., Kaplan M. H., Clogston A.G. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptides antibiotics. J Infect Dis 1990; 161:37-40.
  • 25. Mathur T., Singhal S., Khan S., Upadhyay D., Fatma T., Rattan A. Adverse effect of staphylococci slime on in vitro activity of glycopeptides. Jpn J Infect Dis 2005; 58:353-7.
  • 26. Singh R., Ray P., Das A., Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 2010; 65:1955-8.
  • 27. Nichols W.W., Dorrington S.M., Slack M.P.E., Walmsley H.L. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob Agents Chemother 1988; 32:518-23.
  • 28. Dunne W.M. Jr., Mason E.O. Jr., Kaplan S.L. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother 1993; 37:2522-6.
  • 29. Durack D.T. Experimental bacterial endocarditis. IV Structure and evolution of very early lesions. J Pathol 1975; 115:81-9.
  • 30. Donlan R.M. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002; 8:881-90.
  • 31. Walters M.S., Roe F., Bugnicourt A., Franklin M.J., Stewart P.S. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003; 47:317-23.
  • 32. Borriello G., Werner E., Roe F., et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 2004; 48:2659-64.
  • 33. Anderl J.N., Zahller J., Roe F., Stewart P.S. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2003; 47:1251-6.
  • 34. Harriott M.M., Noverr M.C. Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation. Antimicrob Agents Chemother 2010; 54:3746-55.
  • 35. Brackman G., Cos P., Maes L., Nelis H.J., Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother 2011; 55: 2655-61.
  • 36. Driffield K., Miller K., Bostock J.M., O’Neill A.J., Chopra I. Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother 2008; 61:1053-6.
  • 37. Breidenstein E.B., de la Fuente-Núñez C., Hancock R.E. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 2011; 19:419-26.
  • 38. Kaplan J.B. Antibiotic-induced biofilm formation. Int J Artif Organs 2011; 34:737-51.
  • 39. Cargill J.S., Upton M. Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis. J Clin Pathol 2009; 62:1112-6.
  • 40. Cerca N., Martins S., Sillankorva S., et al. Effects of growth in the presence of subinhibitory concentrations of dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus biofilms. Appl Environ Microbiol 2005; 71: 8677-82.
  • 41. Wozniak D.J., Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004; 125(2 Suppl):62S-69S.
  • 42. Moskowitz S.M., Foster J.M., Emerson J., Burns J.L. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004; 42:1915-22.
  • 43. Frank K.L., Reichert E.J., Piper K.E., Patel R. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother 2007; 51:888-95.
  • 44. Sepandj F., Ceri H., Gibb A., Read R., Olson M. Minimum inhibitory concentration (MIC) versus minimum biofilm eliminating concentration (MBEC) in evaluation of antibiotic sensitivity of gram-negative bacilli causing peritonitis. Perit Dial Int 2004; 24:65-7.
  • 45. Pettit R.K., Weber C.A., Kean M.J., et al. Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 2005; 49:2612-7.
  • 46. Anderl J.N., Franklin M.J., Stewart P.S. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000; 44:1818-24.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared